Skip Navigation

European Heart Journal 1999 20(22):1647-1656; doi:10.1053/euhj.1999.1693
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Willenheimer, R.
Right arrow Articles by Erhardt, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willenheimer, R.
Right arrow Articles by Erhardt, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function

R. Willenheimerf1, E. Rydberg, L. Öberg, S. Juul-Möller and L. Erhardt

Department of Cardiology, Malmö University Hospital, Lund University, Malmö, Sweden

revised May 11, 1999; accepted May 12, 1999

Abstract

Aims To assess the effects of 6 months intervention with ramipril on resting and post exercise left ventricular function in patients with stable ischaemic heart disease and preserved left ventricular systolic function.

Methods and Results Patients (n=98, age 65±9 years, 37% women) were randomized to double-blind treatment with ramipril 5mg.day–1(n=32), ramipril 1·25mg.day–1(n=34), or placebo (n=32). Resting and post maximum exercise echocardiography/Doppler examinations were performed at baseline and after 6 months. Changes over 6 months in resting transmitral E-wave deceleration time (Edt) and Edt adjusted for heart rate (Edt/RR) differed between the ramipril 5mg, ramipril 1·25mg, and placebo groups: Edt 24±82, –1±69, and –29±64ms, respectively, P=0·012; Edt/RR 30±105, 2±61, and –28±69ms, respectively, P=0·015. Changes in the difference between resting and post exercise Edt/RR also varied between groups: –53±137, –28±118, and 35±101ms, respectively,P =0·029. No differences in E/A indices were noted. Resting atrioventricular plane displacement improved in the combined ramipril groups vs the placebo group: 0·2±0·8 vs –0·2±1·3mm, P<0·05.

Conclusion Six months ramipril treatment in patients with stable ischaemic heart disease and preserved left ventricular systolic function improved resting left ventricular function and reduced the exercise induced diastolic filling abnormalities usually seen in these patients.

Key Words: Angiotensin converting enzyme inhibitor, ischaemic heart disease, left ventricular function, diastolic function, exercise

f1 Correspondence: Dr Ronnie Willenheimer, Department of Cardiology, Malmö University Hospital, S-205 02 Malmö, Sweden.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart J SupplHome page
F. Enseleit, T.F. Luscher, and F. Ruschitzka
Angiotensin-converting enzyme inhibition and endothelial dysfunction: focus on ramipril
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A31 - A36.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.